Barinthus Biotherapeutics plc. Quarterly Depreciation in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Barinthus Biotherapeutics plc. quarterly/annual Depreciation history and growth rate from Q1 2022 to Q3 2024.
  • Barinthus Biotherapeutics plc. Depreciation for the quarter ending September 30, 2024 was $700K, unchanged year-over-year.
  • Barinthus Biotherapeutics plc. Depreciation for the twelve months ending September 30, 2024 was $2.7M, a 42.1% increase year-over-year.
  • Barinthus Biotherapeutics plc. annual Depreciation for 2023 was $2.3M, a 109% increase from 2022.
  • Barinthus Biotherapeutics plc. annual Depreciation for 2022 was $1.1M, a 175% increase from 2021.
  • Barinthus Biotherapeutics plc. annual Depreciation for 2021 was $400K, a 92.3% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.7M $700K $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $2.7M $700K +$200K +40% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.5M $600K +$200K +50% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $2.3M $700K +$400K +133% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 $1.9M $700K +$300K +75% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $1.6M $500K +$300K +150% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.3M $400K +$200K +100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $1.1M $300K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 $400K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $200K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $200K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.